Consort Medical (LON:CSRT) subsidiary Bespak said today that it inked a development agreement with an undisclosed biopharmaceutical company for its Syrina auto-injector tech.
The agreement says Bespak is responsible for early stage development of the auto-injector. If the undisclosed partner agrees to commercialize the developed product, both parties will enter into a full commercial supply agreement, according to Bespak.
Get the full story at our sister site, Drug Delivery Business News.
The post Consort Medical inks Syrina auto-injector development agreement appeared first on MassDevice.